Mr. Dunbar has extensive healthcare and life sciences operating experience, and has served as a Director or CEO with private and public companies in Diagnostics, Specialty Pharma, Cell Therapy, and Biologics, two where he led initial public offerings (IPOs). George has served as a Director or CEO with life science companies including Stem Cells, Inc./ CytoTherapeutics, Aastrom (now Vericel) and also DepoTech, Epic Therapeutics, LJL Biosystems, Metra Biosystems, Metrika, Molecular Probes, Quantum Dot, Sonus Pharmaceuticals, and Quidel. He began his career with Motorola’s Communications Division.
Mr. Dunbar has degrees in Electrical Engineering and an MBA from Auburn University, and served on the Harbert College of Business MBA Advisory Board. He is member of the Entrepreneurial Advisory Council with Vanderbilt University’s Center for Technology Transfer and Commercialization.